• LAST PRICE
    0.3560
  • TODAY'S CHANGE (%)
    Trending Up0.0035 (0.9929%)
  • Bid / Lots
    0.3500/ 15
  • Ask / Lots
    0.3600/ 23
  • Open / Previous Close
    0.3600 / 0.3525
  • Day Range
    Low 0.3500
    High 0.3650
  • 52 Week Range
    Low 0.2501
    High 0.9099
  • Volume
    167,479
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.3525
TimeVolumeIGC
09:32 ET124010.36
09:33 ET1130.3526
09:35 ET1000.3598
09:37 ET2500.3598
09:42 ET1000.3597
09:46 ET31000.3597
09:48 ET10760.3573
09:50 ET8840.3597
09:51 ET1000.355
09:53 ET7500.355
10:04 ET1160.3586
10:06 ET2180.35001
10:09 ET4500.3586
10:11 ET1500.3586
10:13 ET1000.3586
10:15 ET4070.3585
10:18 ET3000.3586
10:22 ET10500.3585
10:26 ET1390.358499
10:27 ET6000.3585
10:29 ET1300.3543
10:31 ET1000.3585
10:33 ET1000.3584
10:36 ET2000.3543
10:40 ET1000.3584
10:45 ET1310.3584
10:47 ET1000.3584
10:56 ET2000.3582
10:58 ET6000.3583
11:00 ET3000.3542
11:02 ET1000.3583
11:03 ET10000.3543
11:16 ET4000.3582
11:18 ET2130.3503
11:27 ET1000.3581
11:36 ET2000.3579
11:39 ET1000.358
11:41 ET2700.356592
11:43 ET3000.358
11:45 ET3090.3542
11:48 ET1000.351471
11:54 ET1000.3579
11:56 ET3680.3541
11:59 ET1000.3579
12:01 ET5910.3542
12:03 ET2350.3542
12:06 ET2910.3578
12:10 ET201880.3505
12:12 ET32540.351
12:14 ET118000.3578
12:26 ET1000.3577
12:28 ET31000.3541
12:30 ET23000.354101
12:33 ET1000.3577
12:37 ET1000.3576
12:39 ET2000.3506
12:42 ET1000.351
12:44 ET1000.3576
12:48 ET46260.3575
12:50 ET8130.3574
12:55 ET10250.35425
12:57 ET3000.3574
01:00 ET1000.3574
01:04 ET1970.3574
01:08 ET1000.3574
01:18 ET10150.3574
01:22 ET4000.355821
01:26 ET13030.3559
01:27 ET8000.3559
01:33 ET5510.3575
01:36 ET2750.3575
01:38 ET3650.3544
01:40 ET2000.3574
01:44 ET7820.3575
01:45 ET1000.3544
01:51 ET1000.3575
02:05 ET2890.3575
02:07 ET96970.36
02:09 ET53780.3639
02:12 ET18000.3592
02:18 ET1750.36215
02:21 ET1000.3625
02:23 ET3000.3609
02:25 ET1000.3625
02:27 ET1000.365
02:36 ET27000.3602
02:38 ET1000.365
02:41 ET1360.365
02:43 ET27000.3603
02:52 ET1000.365
02:56 ET2000.365
02:57 ET1000.365
03:01 ET3770.3602
03:06 ET3000.3626
03:12 ET1000.365
03:14 ET4250.3649
03:17 ET32750.362365
03:19 ET2000.3622
03:21 ET14000.3619
03:24 ET5800.3622
03:26 ET1500.3622
03:28 ET1000.3622
03:30 ET6500.361
03:32 ET5000.361
03:33 ET62550.3611
03:35 ET5000.3549
03:37 ET26000.3622
03:48 ET5000.3585
03:51 ET2000.3621
04:00 ET12740.356
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIGC
IGC Pharma Inc
27.6M
-1.9x
---
United StatesLGVN
Longeveron Inc
28.0M
-0.3x
---
United StatesPLUR
Pluri Inc
27.2M
-1.2x
---
United StatesSABS
SAB Biotherapeutics Inc
28.9M
-0.5x
---
United StatesGOVX
GeoVax Labs Inc
27.8M
-0.3x
---
United StatesCLNN
Clene Inc.
31.6M
-0.7x
---
As of 2024-11-23

Company Information

IGC Pharma, Inc. is a clinical-stage company, which is engaged in developing treatments for Alzheimer’s disease. The Company’s flagship drug, IGC-AD1, is an investigational drug tackles agitation, a major burden for patients and caregivers by addressing neuroinflammation. The Company operates through two segments: Life Sciences Segment and Infrastructure Segment. Its TGR-63 has demonstrated its potential to disrupt the progression of Alzheimer’s by targeting Aβ plaques, a key disease hallmark. The Company’s IGC-1C represents a potential breakthrough by targeting tau protein and neurofibrillary tangles, aiming to modify the disease course. Its IGC-M3 focuses on early intervention by inhibiting Aβ plaque formation, potentially slowing cognitive decline. Its LMP is designed to target multiple hallmarks of Alzheimer’s disease, including Aβ plaques and neurofibrillary tangles for a comprehensive therapeutic effect. It seeks to leverage artificial intelligence (AI) for Alzheimer's research.

Contact Information

Headquarters
2405 York Road, Suite 201LUTHERVILLE-TIMONIUM, MD, United States 21093-2264
Phone
301-983-0998
Fax
240-465-0273

Executives

Independent Chairman of the Board
Richard Prins
President, Chief Executive Officer, Director
Ram Mukunda
Vice-President, Principal Financial Officer, Chief Compliance Officer, Director
Claudia Grimaldi
Independent Director
Terry Lierman
Independent Director
James Moran

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$27.6M
Revenue (TTM)
$1.2M
Shares Outstanding
77.4M
IGC Pharma Inc does not pay a dividend.
Beta
1.29
EPS
$-0.19
Book Value
$0.11
P/E Ratio
-1.9x
Price/Sales (TTM)
23.3
Price/Cash Flow (TTM)
---
Operating Margin
-1,070.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.